Ghost Tree Capital, LLC - AMYLYX PHARMACEUTICALS INC ownership

AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 175 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ghost Tree Capital, LLC ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,936,650
-66.8%
215,000
-60.9%
1.30%
-66.9%
Q2 2023$11,863,500
-14.9%
550,000
+15.8%
3.92%
-4.9%
Q1 2023$13,937,000
+7.8%
475,000
+35.7%
4.12%
-25.4%
Q4 2022$12,933,000
-56.2%
350,000
-66.7%
5.52%
-33.4%
Q3 2022$29,558,0001,050,0008.30%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpha Wave Global, LP 853,262$18,404,86112.06%
Stonepine Capital Management, LLC 1,121,028$24,180,5748.72%
GREAT POINT PARTNERS LLC 968,795$20,896,9084.09%
Ghost Tree Capital, LLC 550,000$11,863,5003.92%
Perceptive Advisors 4,873,919$105,130,4333.04%
Altium Capital Management LP 185,000$3,990,4503.02%
Boxer Capital, LLC 2,084,000$44,9522.08%
SECTORAL ASSET MANAGEMENT INC 387,310$8,354,2771.39%
AlphaCentric Advisors LLC 108,000$2,329,5601.29%
EMERALD MUTUAL FUND ADVISERS TRUST 680,035$14,668,3550.80%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders